A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase III Study of Bintrafusp alfa in Combination with Cisplatin or Carboplatin and Paclitaxel with or without Bevacizumab as a First-line Treatment in Participants with Stage IVB, Recurrent or Persistent Carcinoma of the Cervix
PARTNERZY
